Author

Jacob A. Boyer

Observed names: Jacob A. Boyer (16948391), Jacob Boyer

Institutions: Case Comprehensive Cancer Center, Case Western Reserve University

Observed institutions: Pennsylvania State University, Memorial Sloan Kettering Cancer Center, Princeton University, Ludwig Cancer Research, Case Comprehensive Cancer Center, Case Western Reserve University

ORCID: 0000-0001-5651-2337

Observed ORCID: 0000-0001-5651-2337

OpenAlex ID: A5090143432

Senolytic CAR T cells reverse senescence-associated pathologies

2020 · Corina Amor, Judith Feucht, et al. · Nature · 1,085

P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis

2023 · Daniel E. Tylawsky, Hiroto Kiguchi, et al. · Nature Materials · 228

PDF

Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction

2024 · Corina Amor, Inés Fernández-Maestre, et al. · Nature Aging · 223

PDF

Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis

2021 · Radha Mukherjee, Kiran G. Vanaja, et al. · Molecular Cell · 132

PDF

Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth

2021 · Bianca J. Lee, Jacob A. Boyer, et al. · Nature Chemical Biology · 82

Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer

2024 · Hidenori Kitai, Philip H. Choi, et al. · Nature Communications · 39

PDF

Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitors

2025 · Asael Roichman, Qianying Zuo, et al. · Cell · 35

Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c–c motif) Ligand 20

2015 · Tejas S. Lahoti, Jacob A. Boyer, et al. · Toxicological Sciences · 35

PDF

Editor’s Highlight: Ah Receptor Activation Potentiates Neutrophil Chemoattractant (C-X-C Motif) Ligand 5 Expression in Keratinocytes and Skin

2017 · Kayla J. Smith, Jacob A. Boyer, et al. · Toxicological Sciences · 30

Anti-uPAR CAR T cells reverse and prevent aging-associated defects in intestinal regeneration and fitness

2025 · Onur Eskiocak, Joseph Gewolb, et al. · Nature Aging · 22

Allelic variants of the aryl hydrocarbon receptor differentially influence UVB-mediated skin inflammatory responses in SKH1 mice

2017 · Kayla J. Smith, Iain A. Murray, et al. · Toxicology · 11

Senolytic CAR T cells reverse aging-associated defects in intestinal regeneration and fitness

2024 · Onur Eskiocak, Saria Chowdhury, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 10

PDF

Author Correction: Senolytic CAR T cells reverse senescence-associated pathologies

2024 · Corina Amor, Judith Feucht, et al. · Nature · 9

PDF

Micromapping (µMap) of HER2 Across Human Breast Cancers: Photocatalytic Proximity Labeling Identifies Primary Resistance Mechanisms and Functional Interactors

2025 · Steve D. Knutson, Jacob A. Boyer, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 7

Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration

2025 · Sunyana Gadal, Jacob A. Boyer, et al. · Cancer Research · 6

A Ketogenic Diet Sensitizes Pancreatic Cancer to Inhibition of Glutamine Metabolism

2024 · Omid Hajihassani, Mehrdad Zarei, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4

A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer

2023 · M. Dorso, Payal T. Patel, et al. · Cancer Research Communications · 4

PDF

Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth

2021 · Bianca J. Lee, Jacob A. Boyer, et al. · Nature Chemical Biology · 2

PDF

Tumorigenesis driven by the BRAF V600E oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion

2023 · Sunyana Gadal, Jacob A. Boyer, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

PDF

Abstract 6805: A ketogenic diet sensitizes pancreatic cancer to metabolic therapies

2026 · Omid Hajihassani, Asael Roichman, et al. · Cancer Research

Supplementary Figure 2 from PAX3-FOXO1 Drives Targetable Cell State–Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma